has vastly improved the quality of life for those suffering from aortic stenosis, a deadly heart condition. The FDA recently announced that it is now approved in all 50 states, and the benefits are tremendous.

For those who suffer from aortic stenosis, the main benefit is the ability to avoid open-heart surgery and have a minimally invasive procedure done. It commonly takes only 2-3 hours to replace the aortic valve, instead of a 6-7 hour open-heart surgery. Secondly, this new procedure also has a much lower mortality rate than traditional open-heart surgery. Unfortunately, with open-heart surgery there is still an unacceptably high risk of death or stroke. However, with Tavr, the risks are much lower, making this procedure a much safer option for patients.

The eligibility criteria for this procedure are also rather generous. Most patients over age 65, and several select younger patients can qualify for the procedure. This low barrier to entry creates a welcomed opportunity for thousands of patients who would have been denied the benefit of a safer procedure due to age.

The real

Article Created by A.I.